Ian F Smith

Director; Director, Chief Executive Officer · 6 filings · Latest: Jul 2, 2026

Foghorn Therapeutics Inc.

Odyssey Therapeutics, Inc.

Solid Biosciences Inc.

Stoke Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SLDB	Ian F Smith	Director	Jul 2, 2026	Option Exercise	—	3,440	—	138,145	Jul 7 8:05 PM
SLDB	Ian F Smith	Director	Apr 2, 2026	Option Exercise	—	3,441	—	134,705	Apr 2 8:05 PM